Research Use Only — Not for Human Consumption. 21+ Required.

Accessibility Statement

Last updated: June 2026

Our Commitment

Axios Peptides LLC is committed to ensuring digital accessibility for people with disabilities. We are continually improving the user experience for everyone and applying the relevant accessibility standards to our website.

Conformance Target

We aim to conform to the Web Content Accessibility Guidelines (WCAG) 2.1 Level AA. These guidelines explain how to make web content more accessible to people with a wide range of disabilities, including visual, auditory, physical, speech, cognitive, and neurological impairments.

Measures We Take

  • Semantic HTML and labelled form controls throughout the site
  • Descriptive alternative text on meaningful imagery
  • Keyboard navigability with visible focus indicators
  • Color-contrast review against WCAG AA ratios
  • Ongoing review of new features for accessibility impact

Known Limitations

Despite our efforts, some content may not yet be fully accessible. We are actively working to identify and remediate remaining issues. We do not rely on third-party accessibility overlay widgets as a substitute for remediation.

Feedback

If you encounter an accessibility barrier on this website, please contact us so we can assist you and improve the experience:

Email: support@axiospeptides.com

We aim to respond to accessibility feedback within 1–2 business days.

Research Updates

Stay
Informed

Receive research updates, new compound announcements, and updated Certificate of Analysis releases.

Research Notifications

Enter your email to receive scientific updates from Axios Peptides.

By subscribing you agree to our Privacy Policy